Search research articles
Contact Us
Filters
Showing results (1-10 of 390) with videos related to
Page
of 39
Sort By:
Nature Reviews. Clinical Oncology
|
November 3, 2025
Intervening on dormancy to prevent breast cancer recurrence
Tanja Fehm, Hans Neubauer
Breast Care (Basel, Switzerland)
|
September 2, 2014
Targeted and Osteo-Oncologic Treatment in Early Breast Cancer: What Is State-of-the-Art and What Might Become so within the Next 5 Years?
Elmar Stickeler, Tanja Fehm
Breast Care (Basel, Switzerland)
|
February 24, 2017
Pathway Oriented Therapy in Breast Cancer - a Light at the End of the Tunnel!
Eugen Ruckhäberle, Tanja Fehm
Deutsche Medizinische Wochenschrift (1946)
|
December 4, 2018
[Systemic Treatment of Early and Metastatic Breast Cancer]
Tanja Fehm, Volkmar Müller
Breast Cancer Research and Treatment
|
February 18, 2011
Circulating free DNA: a new surrogate marker for minimal residual disease?
Tanja Fehm, Malgorzata Banys
Cancers
|
January 18, 2014
The role and clinical relevance of disseminated tumor cells in breast cancer
Malgorzata Banys, Natalia Krawczyk, Tanja Fehm
Breast Cancer Research and Treatment
|
September 24, 2002
Clinical utility of serial serum c-erbB-2 determinations in the follow-up of breast cancer patients
Tanja Fehm, Gerhard Gebauer, Wolfram Jäger
Chirurgia (Bucharest, Romania : 1990)
|
December 30, 2021
DCIS in Male and Aged Women with Comorbidities
Natalia Krawczyk, Tanja Fehm, Maggie Banys-Paluchowski
Advances in Experimental Medicine and Biology
|
April 19, 2020
Disseminated Tumor Cells and Dormancy in Breast Cancer Progression
Malgorzata Banys-Paluchowski, Florian Reinhardt, Tanja Fehm
Frontiers in Oncology
|
December 20, 2016
Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence
Malgorzata Banys-Paluchowski, Natalia Krawczyk, Tanja Fehm
Page
of 39
Search research articles
Search
Showing results (1-10 of 390) with videos related to
Sort By:
Page
of 39
Nature Reviews. Clinical Oncology
|
November 3, 2025
Intervening on dormancy to prevent breast cancer recurrence
Tanja Fehm, Hans Neubauer
Breast Care (Basel, Switzerland)
|
September 2, 2014
Targeted and Osteo-Oncologic Treatment in Early Breast Cancer: What Is State-of-the-Art and What Might Become so within the Next 5 Years?
Elmar Stickeler, Tanja Fehm
Breast Care (Basel, Switzerland)
|
February 24, 2017
Pathway Oriented Therapy in Breast Cancer - a Light at the End of the Tunnel!
Eugen Ruckhäberle, Tanja Fehm
Deutsche Medizinische Wochenschrift (1946)
|
December 4, 2018
[Systemic Treatment of Early and Metastatic Breast Cancer]
Tanja Fehm, Volkmar Müller
Breast Cancer Research and Treatment
|
February 18, 2011
Circulating free DNA: a new surrogate marker for minimal residual disease?
Tanja Fehm, Malgorzata Banys
Cancers
|
January 18, 2014
The role and clinical relevance of disseminated tumor cells in breast cancer
Malgorzata Banys, Natalia Krawczyk, Tanja Fehm
Breast Cancer Research and Treatment
|
September 24, 2002
Clinical utility of serial serum c-erbB-2 determinations in the follow-up of breast cancer patients
Tanja Fehm, Gerhard Gebauer, Wolfram Jäger
Chirurgia (Bucharest, Romania : 1990)
|
December 30, 2021
DCIS in Male and Aged Women with Comorbidities
Natalia Krawczyk, Tanja Fehm, Maggie Banys-Paluchowski
Advances in Experimental Medicine and Biology
|
April 19, 2020
Disseminated Tumor Cells and Dormancy in Breast Cancer Progression
Malgorzata Banys-Paluchowski, Florian Reinhardt, Tanja Fehm
Frontiers in Oncology
|
December 20, 2016
Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence
Malgorzata Banys-Paluchowski, Natalia Krawczyk, Tanja Fehm
Page
of 39